Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Inventory (2022 - 2026)

HeartSciences (HSCS) has disclosed Inventory for 4 consecutive years, with $657285.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Inventory rose 0.67% year-over-year to $657285.0, compared with a TTM value of $657285.0 through Oct 2025, up 0.67%, and an annual FY2025 reading of $650267.0, up 3.35% over the prior year.
  • Inventory was $657285.0 for Q4 2025 at HeartSciences, up from $649507.0 in the prior quarter.
  • Across five years, Inventory topped out at $677669.0 in Q3 2022 and bottomed at $629179.0 in Q2 2024.
  • Average Inventory over 4 years is $662570.1, with a median of $670278.0 recorded in 2024.
  • The sharpest move saw Inventory decreased 6.98% in 2024, then rose 3.35% in 2025.
  • Year by year, Inventory stood at $677669.0 in 2022, then fell by 0.42% to $674839.0 in 2023, then decreased by 3.25% to $652907.0 in 2024, then rose by 0.67% to $657285.0 in 2025.
  • Business Quant data shows Inventory for HSCS at $657285.0 in Q4 2025, $649507.0 in Q3 2025, and $650267.0 in Q2 2025.